Content about Pharmaceuticals policy

July 14, 2010
Keryx gets orphan-drug designation for neuroblastoma treatment

The Food and Drug Administration has given special designation to an investigational treatment for a...

July 14, 2010
Mylan acquires Bioniche Pharma

Generic drug maker Mylan is hoping to gain entry into the injectable drug market with...

July 13, 2010
Teva launches generic Amerge

Teva Pharmaceuticals has launched a drug for treating migraine headaches, the generic drug maker said....

NORTH WALES, Pa. Teva Pharmaceuticals has launched a drug for treating migraine headaches, the generic drug maker said.

 

Teva announced the launch of naratriptan tablets in the 1 mg and 2.5-mg strengths. The tablets are a generic version of GlaxoSmithKline’s Amerge. The drug is used to treat acute migraine attacks in adults with or without visual disturbances preceding the attacks known as aura.

 

 

July 12, 2010
Centric Health Resources head to address 5th Annual Rare Disease Leadership Summit

The 5th Annual Rare Disease Leadership Summit being held Wednesday in Arlington, Va., will feature...

July 12, 2010
PhRMA names new president, CEO

The main lobby for the pharmaceutical industry has appointed the president and CEO of Business...

July 11, 2010
Domann named Kerr Health's VP sales and business

Regional retail pharmacy chain Kerr Drug has hired former GlaxoSmithKline and Johnson & Johnson executive...

July 8, 2010
Roxane launches generic Amerge, Arimidex

Roxane Labs announced Thursday the launch of two new generic drugs....

COLUMBUS, Ohio Roxane Labs announced Thursday the launch of two new generic drugs.

 

The Columbus, Ohio-based generics subsidiary of German drug maker Boehringer Ingelheim, launched naratriptan tablets in the 1-mg and 2.5-mg strengths, and anastrozole tablets in the 1-mg strength.

 

 

July 6, 2010
Caraco begins shipment of generic Optivar

Generic drug maker Caraco Pharmaceutical Labs has begun shipping azelastine ophthalmic solution in the 0.05%...

July 6, 2010
Dr. Reddy's receives regulatory approval for three generic drugs

Dr. Reddy’s Labs has received approval from the Food and Drug Administration and launched three...

July 5, 2010
Fougera's generic Differin gets green light from FDA

The Food and Drug Administration has approved a topical drug for acne made by E....

July 5, 2010
Jean Coutu Group reports increase in revenue

The Jean Coutu Group on Tuesday reported a 3.8% increase in revenues to $611.6 million...

June 30, 2010
MTM bill's bark matches its bite

The Senate medication therapy management bill, introduced on June 29 by Sen. Kay Hagan, D-N.C.,...

WHAT IT MEANS AND WHY IT'S IMPORTANT The Senate medication therapy management bill, introduced on June 29 by Sen. Kay Hagan, D-N.C., has been backed by the National Association of Chain Drug Stores and the National Community Pharmacists Association -- and for good reason. For health reform to have any real teeth, MTM needs to be a meaningful part of it -- and if MTM is going to have any real teeth, retail pharmacy needs to be a part of it.

June 30, 2010
Par, Prasco launch GERD treatment

Generic drug maker Par Pharmaceutical has launched a generic version of a drug used to...

June 29, 2010
Court upholds Crestor patent

The U.S. District Court for the District of Delaware has upheld the patent on a...

June 29, 2010
Expect to see growth from Novartis, Datamonitor says

Some of the strongest growth among large drug companies may come from Swiss drug maker...

June 28, 2010
Generic drug makers launch anastrozole tablets

The Food and Drug Administration has approved two new generic versions of a drug for...

June 28, 2010
Teva's generic Effexor XR receives regulatory approval

The Food and Drug Administration has approved the first generic version of an extended-release antidepressant...

June 24, 2010
CRN: Dietary supplement manufacturers must be GMP-compliant

The Council for Responsible Nutrition on Friday noted that all dietary supplement manufacturers without exception...

June 24, 2010
Dietary supplement industry gets its due with GMP requirements

The dietary supplement industry is free at last from any major news organization making any...

WHAT IT MEANS AND WHY IT'S IMPORTANT The dietary supplement industry is free at last from any major news organization making any kind of assertion that the industry is “unregulated.”

(THE NEWS: CRN: Dietary supplement manufacturers must be GMP-compliant. For the full story, click here)

June 24, 2010
Mail-order pharmacy biz may get thwarted by postal service

Community pharmacy never really was able to stop the mail-order juggernaut. Maybe the cash-strapped U.S....

WHAT IT MEANS AND WHY IT’S IMPORTANT Community pharmacy never really was able to stop the mail-order juggernaut. Maybe the cash-strapped U.S. postal service will.

(THE NEWS: Plan to cut Saturday postal service draws heat from mail-order pharmacy. For the full story, click here)

June 22, 2010
Cephalon expands When Good Medicines Become Bad Drugs program with new partnership

Drug maker Cephalon has started a partnership with the American Chronic Pain Association and the...

June 17, 2010
Teva admits making false claims about contraceptive

Teva Pharmaceutical Industries admitted before a federal court Thursday to making false statements about the...

June 16, 2010
Indie pharmacy applauds move in Congress to end aggressive Part B recoupment efforts

The independent pharmacy lobby is hailing a new effort by congressional Democrats to shield owner-operated...

June 13, 2010
Gilead patent for Ranexa challenged by Lupin

Indian generic drug maker Lupin is challenging a Gilead Sciences patent for a drug that...

June 10, 2010
NACDS claims victory for pharmacies, patients in South Carolina

The National Association of Chain Drug Stores praised a provision in legislation passed Thursday that...